CABLIVI

Google image searchProduct monograph

Active ingredient

caplacizumab, 11 MG/VIAL

DIN: 02496194

Dosage form(s): KIT, POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 04-SEP-2020

ATC:

• B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
• B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
• B01AX — Other antithrombotic agents (ATC, ATC/DDD)
• B01AX07 — CAPLACIZUMAB (ATC/DDD)

Reference brand drug: Cablivi

External Links for Cablivi

Search on Google

• Cablivi side effects
• Cablivi dosage
• caplacizumab side effects
• caplacizumab dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find cablivi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.